Statin use and survival in elderly patients with endometrial cancer

Gynecologic Oncology

Volumn 137, Issue 2, 2015, Pages 252-257

  Yoon, Lara S ^a   Goodman, Marc T ^b   Rimel, B J ^b   Jeon, Christie Y ^b  

^a Columbia University ^*  (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Elderly; Endometrial cancer; HMG CoA reductase inhibitor; Statin; Survival

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL HYSTERECTOMY; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOMETRIUM CANCER; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MORBID OBESITY; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VAGINAL HYSTERECTOMY; CANCER REGISTRY; ENDOMETRIUM TUMOR; EPIDEMIOLOGY; PATHOLOGY; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84933280337     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.01.549     Document Type: Article

References (17)

1. National Cancer Institute Statins and Cancer Prevention. Fact sheet. http://www.cancer.gov/cancertopics/factsheet/prevention/statins.
2. Corcos L, Le Jossic-Corcos C. Statins: perspectives in cancer therapeutics. Dig Liver Dis 2013;45:795-802.
3. Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One 2013;8:e62823.
4. Kotamraju S, Williams CL, Kalyanaraman B. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res 2007; 67:7386-94.
5. Koyuturk M, Ersoz M, Altiok N. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK. Cancer Lett 2007;250:220-8.
6. Moreau AS, Jia X, Patterson CJ, et al. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia. Br J Haematol 2008;142:775-85.
7. Qi XF, Zheng L, Lee KJ, et al. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. Cell Death Dis 2013;4:e518.
8. Schointuch MN, Gilliam TP, Stine JE, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol 2014;134(2):346-55.
9. Lavie O, Pinchev M, Rennert HS, Segev Y, Rennert G. The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol 2013;130:615-9.
10. National Cancer Institute. Overview of the SEER program. http://seer.cancer.gov/about/overview.html; 2014.
11. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEERMedicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV-3-IV-18.
12. National Cancer Institute. SEER-medicare linked database. http://appliedresearch. cancer.gov/seermedicare/; 2013.
13. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2889-934.
14. Applied Research Program CoCCaPS, National Cancer Institute. Procedure codes for SEER-Medicare analyses. http://appliedresearch.cancer.gov/seermedicare/considerations/procedure-codes.html>
15. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol Feb 15 2008;167(4):492-9 (Pub Med PMID: 18056625).
16. Brewer TM, Masuda H, Liu DD, Shen Y, Liu P, Iwamoto T, Kai K, Barnett CM, Woodward WA, Reuben JM, Yang P, Hortobagyi GN, Ueno NT. Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer 2013;109(2):318-24.
17. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature May 2 2013;497(7447): 67-73.